This roadmap is a starting line, not a ceiling. Ēnel’s portfolio grows through three submission pathways — each subject to the same independent scientific review.
- Brand submissions. Established and emerging brands submit products for validation. Their data, sourcing, and identity are reviewed against the same scientific standard as every other entry. No paid placement, no expedited review, no veto over the published result — a brand can pay to be tested, never to be approved.
- Developer submissions. Independent makers, academic researchers, and traditional or indigenous producers propose protocols of their own. A zero-cost path exists for undercapitalized submitters: Ēnel waives the validation fee and earns only on consumer purchase commission if the product validates and is sold through the marketplace.
- Crowd-elected submissions. Members vote new topics into the queue each quarter. The roadmap above includes “Product TBA” slots reserved for these community-elected priorities, and the pace accelerates as the member base grows.
Every submission — whether from a multinational, a solo formulator, an academic lab, or a generational practitioner — goes through the same independent ethics review and the same biomarker-validated study design. Six submitter types. One scientific standard. Members always have the final say on what gets prioritized.